
About the EOW 2027
The European Ovary Workshop (EOW) is an international scientific meeting dedicated to advancing research and clinical practice in ovarian biology, fertility preservation, and women’s reproductive health.
EOW brings together leading scientists, clinicians, and innovators in a highly interactive format designed to foster discussion, collaboration, and translational impact.
Unlike large conferences, EOW is intentionally designed as a focused workshop, enabling meaningful exchanges between participants and sponsors.
The 2027 edition will explore ovarian biology from fundamental mechanisms to clinical applications, including emerging technologies, reproductive medicine, and environmental impacts on fertility.
Why Sponsor EOW 2027
Sponsoring EOW offers direct access to a highly specialized international community of experts working at the forefront of ovarian research and reproductive medicine.
The workshop provides an ideal platform for companies developing technologies or therapies related to:
- Fertility treatments
- Reproductive health
- Hormone therapies
- Ovarian aging and menopause
- Fertility preservation
- Reproductive toxicology
- Reproductive biotechnology
Because of the workshop format, sponsors benefit from high visibility and direct interaction with participants, including leading researchers and clinicians.
Benefits For Sponsors

Visibility among international experts in reproductive medicine

Direct interaction with clinicians and translational researchers

Association with cutting-edge research in women’s health

Engagement with early-career scientists shaping the future of the field

Opportunity to showcase technologies and innovations
Clinical and Translational Relevance
Although rooted in fundamental ovarian biology, EOW strongly emphasizes the translation of discoveries into clinical practice.
Key clinical and translational topics include:
- Fertility preservation in cancer patients
- Ovarian aging and reproductive lifespan
- Endocrine regulation of ovarian function
- Ovarian disorders and reproductive endocrinology
- Environmental impacts on female fertility
- Emerging technologies for fertility restoration
- Ovarian models for drug discovery and toxicology testing
These discussions bring together clinicians, translational scientists, and industry partners exploring innovative approaches to improving women’s reproductive health.
Clinical audience
Participants include:
- Reproductive endocrinologists
- Fertility specialists and IVF clinicians
- Gynecologists
- Clinical embryologists
- Translational researchers
- Biotechnology and pharmaceutical researchers
This unique combination of basic scientists and clinicians creates valuable opportunities for industry partners.
Sponsorship Packages
Platinum
€ 8,000
- Premium allocated space in the poster area
- Roll-up banner in the conference room
- Symposium sponsor Networking event sponsor
- Featured sponsor in the event app
- Recognition in opening and closing remarks
- Presentation opportunity
- Logo on holding slides
- Larger logo on event website
Gold
€ 5,000
- Allocated space in the poster area
- Networking event sponsor
- Recognition in opening and closing remarks
- Logo on holding slides
- Medium logo on event website
Silver
€ 2,500
- Allocated space to be confirmed
- Recognition in opening and closing remarks
- Logo on holding slides
- Medium logo on event website
Bronze
€ 1,000
- Logo on holding slides
- Small logo on event website
Scientific Program Overview
The programme is designed to guide participants from fundamental ovarian biology to clinical applications and emerging technologies, with strong integration of translational and clinical perspectives.
| March 8th (Monday) | ||
| Session 1 | Origins of ovarian potential | Diana Laird – Ovarian reserve: initiation and depletion Luca Jovine – Determinants of oocyte quality |
| Coffee Break | ||
| Session 2 | Ovarian ageing | Neil Hunter – Mechanisms of ovarian ageing Farners Amargant – Clinical impact of ovarian ageing |
| Coffee Break | ||
| Session 3 | Emerging technologies | João Pedro Alves Lopes – In vitro gametogenesis Luz Garcia-Alonso – Single-cell ovarian analysis |
| Poster Session | ||
| March 9th (Tuesday) | ||
| Session 4 | Fertility preservation | Roseanne Rosario – AMH and ovarian protection Isabelle Demeestere – Fertility preservation in cancer patients |
| Coffee Break | ||
| Session 5 | Ovarian disorders | Elisabet Stener-Victorin – PCOS mechanisms and clinical impact |
| Poster Session | ||
| March 10th (Wednesday) | ||
| Session 6 | Environmental impacts | Marjorie van Duursen – Ovarian Toxicology |
| Coffee Break | ||
| Session 7 | Follicular microenvironment | Agne Velthut-Meikas – Extracellular vesicles as biomarkers |
| Lunch Break | ||
| Session 8 | Mechanobiology | Chii Jou Chan – Mechanical regulation of follicles Francesc Fàbregues – Tissue mechanisms and cryopreservation |
| Coffee Break | ||
| Session 9 | Conservation | Sam Ecroyd – Reproductive technologies in wildlife |
| Poster Session | ||
| March 11th (Thursday) | ||
| Session 10 | In vitro follicle culture | Norah Spears – Challenges in follicle culture |
| Scientific Debate | Ovarian models: 3D systems, animal models, and beyond | |
| Closing session & awards | ||
Invited Speakers

Majorie van Duursen
Netherlands

Luca Jovine
Sweden

Neil Hunter
USA

Farners Amargant
USA

Agne Velthut-Meikas
Estonia

Elisabet Stener-Victorin
Sweden

João Pedro Alves Lopes
Sweden

Luz Garcia-Alonso
United Kingdom

Roseanne Rosario
United Kingdom

Isabelle Demeestere
Belgium

Chii Jou Chan
Singapore

Francesc Fabregues
Spain
Organizers

Stine Gry Kristensen
Denmark

Christiani A. Amorim
Belgium

Hajra Khattak
United Kingdom

Michael Klutstein
Israel

Susana C. S. Lopes
Netherlands

Pauliina Damdimopoulou
Sweden

Jennifer Gruhn
Denmark

Suzannah Williams
United Kingdom

Janice Vilela
Belgium
Local Organizers

Ignasi Roig
Spain

Janisse Ferreri
Spain

Marta Mendez
Spain